FKBP5 and cancer: Previous studies showed that upregulation of FKBP5 is associated with drug resistance in various cancers (including breast, prostate, myeloma, acute lymphoblastic leukemia, melanoma) following treatment with antineoplastic agents (FK506, rapamycin, dexamethasone, irradiation) [18–23].